Physician profile
Daniel A Charlick
NPI 1093705063
$5,132.45
in general payments reported to CMS, 2019-2025
10 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.60 · 2020: $2,000 · 2021: $177 · 2022: $1,536 · 2023: $101 · 2024: $817 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Education: $571 · Travel and Lodging: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.69 |
| Education | $570.68 |
| Travel and Lodging | $182.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,403.68 | 2019-2025 | Infinity, Inbone, Infinity Adaptis |
| Arthrex, INC. | $2,000.00 | 2020 | |
| Treace Medical Concepts, INC. | $382.53 | 2023-2025 | |
| Exactech, INC. | $84.30 | 2022 | |
| Smith+Nephew, INC. | $76.63 | 2021 | |
| Zimmer Biomet Holdings, INC. | $65.88 | 2019-2023 | |
| Theragen, INC. | $54.21 | 2024 | Actastim-S |
| Encore Medical, LP | $26.35 | 2022 | |
| Nexus Medical Technologies LLC | $25.28 | 2025 | |
| Depuy Synthes Sales INC. | $13.59 | 2025 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Charlick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.